Affiliation:
1. Centre for Immunology and Infection Control and School of Biomedical Sciences Queensland University of Technology Brisbane Queensland Australia
Abstract
AbstractUrogenital chlamydial infections continue to increase with over 127 million people affected annually, causing significant economic and public health pressures. While the role of traditional MHCI and II peptide presentation is well defined in chlamydial infections, the role of lipid antigens in immunity remains unclear. Natural killer (NK) T cells are important effector cells that recognize and respond to lipid antigens during infections. Chlamydial infection of antigen‐presenting cells facilitates presentation of lipid on the MHCI‐like protein, CD1d, which stimulates NKT cells to respond. During urogenital chlamydial infection, wild‐type (WT) female mice had significantly greater chlamydial burden than CD1d−/− (NKT‐deficient) mice, and had significantly greater incidence and severity of immunopathology in both primary and secondary infections. WT mice had similar vaginal lymphocytic infiltrate, but 59% more oviduct occlusion compared to CD1d−/− mice. Transcriptional array analysis of oviducts day 6 post‐infection revealed WT mice had elevated levels of Ifnγ (6‐fold), Tnfα (38‐fold), Il6 (2.5‐fold), Il1β (3‐fold) and Il17a (6‐fold) mRNA compared to CD1d−/− mice. In infected females, oviduct tissues had an elevated infiltration of CD4+‐invariant NKT (iNKT) cells, however, iNKT‐deficient Jα18−/− mice had no significant differences in hydrosalpinx severity or incidence compared to WT controls. Lipid mass spectrometry of surface‐cleaved CD1d in infected macrophages revealed an enhancement of presented lipids and cellular sequestration of sphingomyelin. Taken together, these data suggest an immunopathogenic role for non‐invariant NKT cells in urogenital chlamydial infections, facilitated by lipid presentation via CD1d via infected antigen‐presenting cells.
Funder
National Health and Medical Research Council
Subject
Immunology,General Medicine
Reference52 articles.
1. WHO.Sexually transmitted infections (STIs). [website]. World Health Organization. Accessed August 22 2022.https://www.who.int/news‐room/fact‐sheets/detail/sexually‐transmitted‐infections‐(stis)
2. Centers for Disease Control and Prevention.National Overview ‐ Sexually Transmitted Disease Surveillance.2019. U.S Department of Health & Human Services. Accessed April 13 2021.https://www.cdc.gov/std/statistics/2019/overview.htm#Chlamydia
3. Estimating the Direct Medical Costs and Productivity Loss of Outpatient Chlamydia and Gonorrhea Treatment
4. Genital Chlamydial Infections
5. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献